BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32665132)

  • 1. Transcatheter Aortic Valve Implantation Readmissions in the Current Era (from the National Readmission Database).
    Tripathi B; Nerusu LA; Sawant AC; Atti L; Sharma P; Pershad A
    Am J Cardiol; 2020 Sep; 130():115-122. PubMed ID: 32665132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.
    Kolte D; Khera S; Sardar MR; Gheewala N; Gupta T; Chatterjee S; Goldsweig A; Aronow WS; Fonarow GC; Bhatt DL; Greenbaum AB; Gordon PC; Sharaf B; Abbott JD
    Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28034845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiologies and Predictors of 30-Day Readmission and In-Hospital Mortality During Primary and Readmission After Transcatheter Aortic Valve Implantation.
    Panaich SS; Arora S; Patel N; Lahewala S; Agrawal Y; Patel NJ; Shah H; Patel V; Deshmukh A; Schreiber T; Grines CL; Badheka AO
    Am J Cardiol; 2016 Dec; 118(11):1705-1711. PubMed ID: 27677388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Impact of Care Fragmentation on Outcomes After Transcatheter Aortic Valve Implantation.
    Hirji SA; Zogg CK; Vaduganathan M; Kiehm S; Percy ED; Yazdchi F; Pelletier M; Shah PB; Bhatt DL; O'Gara P; Kaneko T
    Am J Cardiol; 2020 Aug; 128():113-119. PubMed ID: 32650903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study).
    Tripathi A; Flaherty MP; Abbott JD; Fonarow GC; Khan AR; Saraswat A; Chahil H; Kolte D; Elmariah S; Hirsch GA; Mathew V; Kirtane AJ; Bhatt DL
    Am J Cardiol; 2018 Aug; 122(3):431-439. PubMed ID: 29960664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Costs and Risk Factors of 30-Day Readmissions for Transcatheter Aortic Valve Implantation.
    Arora S; Hendrickson MJ; Strassle PD; Qamar A; Pandey A; Kolte D; Sitammagari K; Cavender MA; Fonarow GC; Bhatt DL; Vavalle JP
    Am J Cardiol; 2020 Dec; 137():89-96. PubMed ID: 32991853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
    Ogami T; Kliner DE; Toma C; Serna-Gallegos D; Wang Y; Brown JA; Yousef S; Sultan I
    Catheter Cardiovasc Interv; 2023 Jan; 101(1):170-177. PubMed ID: 36478377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same-Day Discharge After Transcatheter Aortic Valve Implantation: Insights from the Nationwide Readmission Database 2015 to 2019.
    Zahid S; Rai D; Tanveer Ud Din M; Khan MZ; Ullah W; Usman Khan M; Thakkar S; Hussein A; Baibhav B; Rao M; Abtahian F; Bhatt DL; Depta JP
    J Am Heart Assoc; 2022 Jun; 11(11):e024746. PubMed ID: 35621233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI.
    Malik AH; Yandrapalli S; Zaid S; Shetty S; Athar A; Gupta R; Aronow WS; Goldberg JB; Cohen MB; Ahmad H; Lansman SL; Tang GHL
    Am J Cardiol; 2020 Jul; 127():120-127. PubMed ID: 32402487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Frequency of Late Gastrointestinal Bleeding With Transcatheter Versus Surgical Aortic Valve Replacement.
    Iyengar A; Sanaiha Y; Aguayo E; Seo YJ; Dobaria V; Toppen W; Shemin RJ; Benharash P
    Am J Cardiol; 2018 Nov; 122(10):1727-1731. PubMed ID: 30316451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State.
    Hannan EL; Samadashvili Z; Jordan D; Sundt TM; Stamato NJ; Lahey SJ; Gold JP; Wechsler A; Ashraf MH; Ruiz C; Wilson S; Smith CR
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002744. PubMed ID: 26227347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Readmission After Surgical Aortic Valve Replacement in the United States.
    Khoury H; Ragalie W; Sanaiha Y; Boutros H; Rudasill S; Shemin RJ; Benharash P
    Ann Thorac Surg; 2020 Sep; 110(3):849-855. PubMed ID: 31981500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
    Zahid S; Din MTU; Khan MZ; Rai D; Ullah W; Sanchez-Nadales A; Elkhapery A; Khan MU; Goldsweig AM; Singla A; Fonarrow G; Balla S
    J Am Heart Assoc; 2022 Aug; 11(16):e024890. PubMed ID: 35929464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early readmissions after transcatheter and surgical aortic valve replacement.
    Vejpongsa P; Bhise V; Charitakis K; Vernon Anderson H; Balan P; Nguyen TC; Estrera AL; Smalling RW; Dhoble A
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):662-670. PubMed ID: 28251807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of In-Hospital Outcomes and Readmission Rates of Transcatheter Aortic Valve Implantation in Mixed Aortic Valve Disease Versus Pure Aortic Stenosis.
    Grant JK; Rubin P; Chambers S; Dangl M; Vincent L; Ebner B; Maning J; Olorunfemi O; Colombo R; Braghiroli J
    Am J Cardiol; 2022 Jul; 175():72-79. PubMed ID: 35562299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital readmission following transcatheter aortic valve implantation in the real world.
    Arai T; Yashima F; Yanagisawa R; Tanaka M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Araki M; Tada N; Yamanaka F; Shirai S; Yamamoto M; Hayashida K;
    Int J Cardiol; 2018 Oct; 269():56-60. PubMed ID: 30064926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and predictors of hospital readmission after transcatheter aortic valve implantation.
    Franzone A; Pilgrim T; Arnold N; Heg D; Langhammer B; Piccolo R; Roost E; Praz F; Räber L; Valgimigli M; Wenaweser P; Jüni P; Carrel T; Windecker S; Stortecky S
    Eur Heart J; 2017 Jul; 38(28):2211-2217. PubMed ID: 28430920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Economic Status on Utilization and Outcomes of Transcatheter Aortic Valve Implantation and Mitraclip.
    Farwati M; Saad AM; Jain V; Ahuja KR; Bansal A; Gad MM; Isogai T; Abdelfattah O; Shekhar S; Kassis N; Hariri E; Svensson L; Krishnaswamy A; Kapadia S
    Am J Cardiol; 2021 Mar; 142():116-123. PubMed ID: 33285094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital variation of 30-day readmission rate following transcatheter aortic valve implantation.
    Ando T; Ashraf S; Kuno T; Briasoulis A; Takagi H; Grines C; Malik A
    Heart; 2022 Feb; 108(3):219-224. PubMed ID: 33627399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.